Sukumar Nagendran

President and Head of R&D, Director, Taysha Gene Therapies, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.3M

Companies

Latest trade

Jul 10, 2026

Companies

Taysha Gene Therapies, Inc.President and Head of R&D, Director −$5.3M

Trades

TSHA Sold 200,000 shares at $6.24 · planned $1.2M Jul 10

TSHA Sold 200,000 shares at $4.46 · planned $0.9M Apr 10

TSHA Sold 26,918 shares at $4.61 $0.1M Jan 26

TSHA Sold 89,132 shares at $4.75 $0.4M Jan 23

TSHA Sold 200,000 shares at $4.71 · planned $0.9M Jan 12

TSHA Sold 260,047 shares at $4.51 $1.2M Dec 1

TSHA Sold 110,125 shares at $4.75 $0.5M Nov 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.